Portfolio Company · Operating Co.

Eximia

Pharmaceutical Services

backed byVSS Capital Partners

CurrentPharmaceutical Services

Eximia

a portfolio company of

VSS Capital Partners

Status on record: Current

Investment year: 2023

PE Firm Index

Who owns Eximia?

Eximia is listed as a current portfolio company of VSS Capital Partners on VSS Capital Partners' own portfolio page. VSS Capital Partners has owned Eximia since 2023, per VSS Capital Partners' portfolio page.

Company Snapshot

Eximia is a Pharmaceutical Services company. Its owner on record, VSS Capital Partners, is a firm. VSS Capital Partners lists 178 companies in the index, 34 of them in Pharmaceutical Services.

SectorPharmaceutical Services

Parent PE firmVSS Capital Partners

Ownership statusCurrent

WebsiteNot on record

About the owner

VSS Capital Partners

Companies in the index: 178

Private investment firm focused on business services, health care and education.

Read the VSS Capital Partners profile

Questions about Eximia

Who owns Eximia?

What sector is Eximia in?

Eximia is in Pharmaceutical Services. Classified from the owner's portfolio label.

What else does VSS Capital Partners own in Pharmaceutical Services?

VSS Capital Partners lists 33 other Pharmaceutical Services companies in the index, including AAC, Ambulatory Anesthesia Care, Ascent, Ascent Behavioral Health and Avatar International.

Sources

VSS Capital Partners
https://www.vss.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Eximia and does not provide investment advice.

Other portfolio companies of VSS Capital Partners

6 of 177 shown

Advanstar Communications

Others

Ambulatory Anesthesia Care

Healthcare Services

See the full VSS Capital Partners portfolio.

Other Pharmaceutical Services companies held by VSS Capital Partners

AAC Ambulatory Anesthesia Care Ascent Ascent Behavioral Health Avatar International Avatar Solutions

Other Pharmaceutical Services portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

VSS Capital Partners

Status: Current

Investment year: 2023

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.